Thursday, June 11, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home European Markets

ASML’s Social Pact Turns Redundancy Into Reassignment as Shares Flirt With Record

SiterGedge by SiterGedge
June 11, 2026
in European Markets, Semiconductors, TecDAX
0
Asml Stock
0
SHARES
10
VIEWS
Share on FacebookShare on Twitter

ASML shares surged toward an all-time high this week after the Dutch chip-equipment giant sealed a revised social plan with labor unions, vastly reducing the scale of planned job cuts. The stock hit €1,573.60 on Thursday, just a whisker below its fresh record of €1,580, adding nearly 59% since the start of the year. Investors cheered the clarity: a leaner, less bureaucratic company without the heavy cost of mass layoffs.

Fewer Pink Slips, More Internal Moves

The original restructuring announced in January 2026 targeted roughly 1,700 positions in the Netherlands and the United States — about 4% of the workforce. Under the new agreement with Dutch unions, that number could be cut in half. The focus has shifted from compulsory redundancies to internal reassignments, with affected employees given until May 2027 to find a new role within the company. Those who do leave will receive severance packages of up to €400,000.

The union FNV continues to push for zero compulsory layoffs. ASML spokesperson Monique Mols confirmed that all employees whose jobs are at risk will be informed by the end of June.

The cuts are concentrated in development, IT, and management layers. ASML identified an excess of coordination roles — project leaders, scrum masters, release train engineers, program managers — that accumulated during years of integration after acquisitions. Chief Financial Officer Roger Dassen has argued the company became too complex, with staff spending too much time on process coordination instead of actual innovation.

Profitability Provides the Cover

This is no distress-driven downsizing. ASML’s first-quarter EBIT came in at €3.2 billion, 4% above analyst estimates. The company raised its full-year 2026 revenue guidance to between €36 billion and €40 billion, up from a previous range of €34 billion to €39 billion. Gross margin is expected to land between 51% and 53%.

Should investors sell immediately? Or is it worth buying Asml?

The revenue lift is powered by surging demand from TSMC, Samsung, and other chip giants building out artificial-intelligence infrastructure. China’s share of ASML sales is slipping from 33% in 2025 to an estimated 20% in 2026, but the AI-driven orders from elsewhere more than fill the gap.

Analyst Targets Reach for €1,900

The Street has responded with a flurry of upgrades. JPMorgan reiterated its buy rating with a €1,921 price target, citing expanding margins and secular growth. Bank of America’s Didier Scemama lifted his target from €1,710 to the same €1,921 level, maintaining a buy. Barclays followed suit, raising its target to €1,900 with an “overweight” rating. Goldman Sachs boosted its revenue estimates for 2026 through 2030 by 6% to 10%, pointing to sustained demand for leading-edge chip nodes used in AI workloads.

ASML’s market capitalization has blown past $700 billion — the first European-listed company to reach that threshold. The stock now sits just 0.4% below its all-time high, with analysts suggesting the restructuring could unlock further operational leverage if executed smoothly.

By cutting coordination fat rather than core engineering muscle, ASML is positioning itself to sprint into the next wave of chip-making technology. The social pact buys time — and investor confidence.

Ad

Asml Stock: Buy or Sell?! New Asml Analysis from June 11 delivers the answer:

The latest Asml figures speak for themselves: Urgent action needed for Asml investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 11.

Asml: Buy or sell? Read more here...

Tags: ASML
SiterGedge

SiterGedge

Related Posts

Diginex Stock
Crypto Stocks

A $9.6 Billion Regulatory Wave Meets a $150 Million Reality Check for Diginex

June 11, 2026
Sivers Semiconductors Stock
European Markets

Sivers Semiconductors Navigates a Web of Opportunity and Uncertainty Ahead of Pivotal AGM

June 11, 2026
Nvidia Stock
AI & Quantum Computing

Nvidia’s Balancing Act: Apple Cloud Win, Vera CPU Ambition, and a Market on Edge

June 11, 2026
Next Post
Ocugen Stock

Ocugen’s Mutation-Agnostic Gene Therapy Edges Toward FDA Filing as $130M Financing Secures Runway to 2028

Heidelberger Druckmaschinen Stock

Heidelberg Druck’s Radical Overhaul: Production Moves East, Defense Venture Takes Shape Amid Cash Flow Strain

Palantir Stock

Palantir's Revenue Jumps 85% to $1.63B, but CEO Karp Warns AI Industry Is Headed for Nationalization

Recommended

Technology Quantum computing Stock Exchange

ScanSource Inc Reports Disappointing Financial Results and Downward Sales Forecast

2 years ago
Albemarle Stock

Albemarle Stock: Surprise Profit Sparks 6% Rally

11 months ago
Seacor Marine Stock

Legal Setback Compounds Challenges for Offshore Services Provider

9 months ago
ASML Stock

Mixed Messages for ASML Investors

7 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Ocugen’s Mutation-Agnostic Gene Therapy Edges Toward FDA Filing as $130M Financing Secures Runway to 2028

ASML’s Social Pact Turns Redundancy Into Reassignment as Shares Flirt With Record

Alphabet’s $80 Billion Capital Raise Backs a $35 Billion Anthropic Wager Amid Legal and Operational Challenges

D-Wave Quantum: Bridging the Atlantic With a $550M Acquisition and a London Debut

Plug Power’s Two-Pronged Rescue: Asset Sales and a Dilution Vote Collide Amid a 20% Rout

BYD’s Dash for Global Supremacy Encounters Pentagon Hurdles and Home Market Headwinds

Trending

Diginex Stock
Crypto Stocks

Diginex’s $1.5 Billion Goliath Gamble: A Penny Stock’s Fight for Survival and Nasdaq Listing

by Kennethcix
June 11, 2026
0

The clock is ticking for Diginex. With the deadline for a transformative $1.5 billion acquisition expiring on...

Palantir Stock

Palantir’s Revenue Jumps 85% to $1.63B, but CEO Karp Warns AI Industry Is Headed for Nationalization

June 11, 2026
Heidelberger Druckmaschinen Stock

Heidelberg Druck’s Radical Overhaul: Production Moves East, Defense Venture Takes Shape Amid Cash Flow Strain

June 11, 2026
Ocugen Stock

Ocugen’s Mutation-Agnostic Gene Therapy Edges Toward FDA Filing as $130M Financing Secures Runway to 2028

June 11, 2026
Asml Stock

ASML’s Social Pact Turns Redundancy Into Reassignment as Shares Flirt With Record

June 11, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Diginex’s $1.5 Billion Goliath Gamble: A Penny Stock’s Fight for Survival and Nasdaq Listing
  • Palantir’s Revenue Jumps 85% to $1.63B, but CEO Karp Warns AI Industry Is Headed for Nationalization
  • Heidelberg Druck’s Radical Overhaul: Production Moves East, Defense Venture Takes Shape Amid Cash Flow Strain

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com